Macerich Announces Pricing of Public Offering of Common Stock

Macerich is raising equity now but won’t see cash until at least 2026-2027.

What the company is saying

Macerich is telling investors it has priced a large public equity offering—14 million shares at $23.90 each—using forward sale agreements with major banks. The company frames this as a strategic move, emphasizing that all shares are tied to these forward agreements, which allow it to lock in today’s price but delay both share issuance and cash receipt until a future date. The announcement highlights the involvement of prominent underwriters and forward purchasers, including Goldman Sachs, Deutsche Bank, JPMorgan, and Morgan Stanley, to signal institutional confidence and transaction credibility. Macerich stresses that it will use any eventual proceeds for future acquisitions and general corporate purposes, but does not specify any targets or projects. The company is explicit that it will not receive any proceeds at the time of the offering; cash only arrives upon settlement of the forward agreements, which can occur any time up to June 16, 2027. The tone is neutral and factual, with no promotional language or exaggerated claims—management avoids hype and sticks to transaction mechanics. Notably, the announcement omits any discussion of current financial performance, recent results, or the company’s operational outlook. This fits a pattern of transactional updates rather than broader investor engagement, and there is no evidence of a shift in messaging compared to prior communications, though no historical context is provided.

What the data suggests

The numbers disclosed are limited to the mechanics of the offering: 14,000,000 shares at $23.90 per share, with a 30-day underwriter option for 2,100,000 more shares. This implies a potential gross raise of $334.6 million (14 million × $23.90), but the company will not receive these funds until it settles the forward sale agreements, which could be as late as June 2027. There is no information on revenue, earnings, cash flow, debt, or any other financial metric—only the current real estate portfolio size (41 million square feet across 39 retail centers) is disclosed, with no historical comparison. The data is clear about the offering’s structure but silent on the company’s financial trajectory, making it impossible to assess whether Macerich’s financial position is improving or deteriorating. There is also no guidance or targets for how the proceeds will be deployed or what returns are expected. The gap between what is claimed and what is evidenced is significant: the company claims the offering will fund future acquisitions, but provides no detail or quantification. An independent analyst would conclude that, while the transaction is transparent in its mechanics, it is incomplete for any assessment of financial health, value creation, or risk-adjusted return.

Analysis

The announcement is a factual disclosure of a public equity offering structured via forward sale agreements, with clear details on the number of shares, price, and counterparties. While several claims are forward-looking (e.g., intended use of proceeds for future acquisitions, settlement of forward agreements by June 2027), these are standard for such transactions and not presented with promotional or exaggerated language. There is no attempt to overstate immediate benefits or inflate expectations; the company explicitly states it will not initially receive proceeds and that use of funds is contingent on future settlement. The only aspirational element is the intended use of proceeds for acquisitions, but no specific targets or financial impacts are claimed. The gap between narrative and evidence is minimal, and the tone remains measured throughout.

Risk flags

• ●Delayed cash inflow: Macerich will not receive any proceeds from this offering until the forward sale agreements are settled, which could be up to three years away. This means there is no immediate liquidity benefit, and the company’s ability to execute on acquisitions or other uses of capital is deferred.
• ●High forward-looking content: The majority of the company’s claims are forward-looking, including the intended use of proceeds and the timing of settlement. This introduces significant uncertainty, as none of the stated benefits are realized or guaranteed at this stage.
• ●Lack of financial disclosure: The announcement omits all financial performance data—no revenue, earnings, cash flow, or debt figures are provided. This lack of transparency makes it impossible for investors to assess the company’s current financial health or trajectory.
• ●No detail on acquisitions: While the company claims proceeds will fund future acquisitions, there are no specifics on targets, pipeline, or expected returns. This leaves investors with no basis to evaluate the potential impact or risk of the planned capital deployment.
• ●Long execution timeline: The settlement of the forward sale agreements can occur any time up to June 16, 2027. This long window introduces risk that market conditions, company strategy, or capital needs may change, potentially undermining the rationale for the offering.
• ●Potential dilution: Issuing 14 million shares (plus up to 2.1 million more) represents a significant increase in share count, which could dilute existing shareholders if not offset by accretive acquisitions or value creation. The company provides no guidance on how it will mitigate this risk.
• ●Capital intensity with uncertain payoff: The stated use of proceeds is for acquisitions and general corporate purposes, both of which are capital intensive and carry execution risk. Without specifics, investors cannot assess whether the capital will generate adequate returns.
• ●No evidence of institutional follow-through: While major banks are involved as underwriters and forward purchasers, their participation is transactional and does not guarantee long-term support or future deals. Investors should not conflate bookrunner roles with a vote of confidence in the company’s strategy.

Bottom line

For investors, this announcement is a technical update on a large equity offering structured via forward sale agreements, not a signal of immediate financial improvement or strategic breakthrough. The company is clear that it will not receive any cash until the forward agreements are settled, which could be as late as June 2027, and there is no detail on how or when the proceeds will be used. The narrative is credible in its transparency about the transaction mechanics, but provides no evidence or guidance on financial performance, acquisition pipeline, or expected returns. The involvement of major banks as underwriters and forward purchasers is standard for a deal of this size and structure, but does not imply institutional endorsement of Macerich’s long-term prospects. To change this assessment, the company would need to disclose specific acquisition targets, binding agreements, or quantified financial impacts tied to the offering. Investors should watch for updates on settlement timing, actual receipt of proceeds, and any announced acquisitions or capital deployment in future reporting periods. At this stage, the information is worth monitoring but not acting on, as the risks and uncertainties outweigh any near-term benefit. The single most important takeaway is that this is a long-dated, capital-intensive transaction with no immediate upside for shareholders and significant execution risk between now and 2027.

Announcement summary

(NYSE: MAC) The Macerich Company announced it has priced an underwritten public offering of 14,000,000 shares of common stock at a price to public of $23.90 per share, all offered in connection with forward sale agreements. The Company is entering into forward sale agreements with Goldman Sachs & Co. LLC, Deutsche Bank AG, London Branch, JPMorgan Chase Bank, National Association and Morgan Stanley or their affiliates for 14,000,000 shares. The underwriters have a 30-day option to purchase up to an additional 2,100,000 shares of common stock. The offering is expected to close on June 17, 2026, subject to customary closing conditions. The Company will not initially receive any proceeds from the sale of shares by the forward purchasers or their affiliates in the offering. The Company intends to use the net proceeds, if any, it receives upon the future settlement of the forward sale agreements to fund future acquisition opportunities and for general corporate purposes. Macerich currently owns approximately 41 million square feet of real estate, consisting primarily of interests in 39 retail centers.

Disagree with this article?